Cancer Communications
indexed by SCI
BMC

Important notice

 

 

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.
Cancer Communications is published by Wiley from 1 January 2020. The journal website is available at: https://onlinelibrary.wiley.com/journal/25233548

 

 

Cancer Communications 最新影响因子突破5分

Cancer Communications (CJC) 获评“2019中国最具国际影响力学术期刊”


Association of an anaplastic lymphoma kinase pathway signature with cell de-differentiation, neoadjuvant chemotherapy response, and recurrence risk in breast cancer
Dingxie Liu, Yong Wu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/21/2020   doi:10.1002/cac2.12038
Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia
Haizhi Yu, Yafei Yin, Yifang Yi, Zhao Cheng , Wenyong Kuang, Ruijuan Li , Haiying Zhong , Yajuan Cui , Lingli Yuan , Fanjie Gong , Zhihua Wang , Heng Li , Hongling Peng, Guangsen Zhang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/21/2020   doi:10.1002/cac2.12080
Aspirin‐based chemoprevention of colorectal cancer: The role for gut microbiota
Feiyu Diao, Shirong Cai
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/18/2020   doi:10.1002/cac2.12086
A newly discovered role of metabolic enzyme PCK1 as a protein kinase to promote cancer lipogenesis
Hongfei Jiang, Lei Zhu, Daqian Xu, Zhimin Lu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/18/2020   doi:10.1002/cac2.12084
Boron neutron capture therapy: Current status and future perspectives
Mayya Alexandrovna Dymova, Sergey Yurjevich Taskaev , Vladimir Alexandrovich Richter, Elena Vladimirovna Kuligina
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/17/2020   doi:10.1002/cac2.12089
The FTO/miR‐181b‐3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer
Yuanyuan Xu, Shuang Ye, Nan Zhang, Shuhui Zheng, Huatao Liu, Kewen Zhou, Ling Wang, Yue Cao, Peng Sun, Tinghuai Wang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/17/2020   doi:10.1002/cac2.12075
Correlation between the genetic variants of base excision repair (BER) pathway genes and neuroblastoma susceptibility in eastern Chinese children
Zhenjian Zhuo, Chunlei Zhou, Yuan Fang, Jinhong Zhu, Hongting Lu, Haixia Zhou, Haiyan Wu, Yizhen Wang, Jing He
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/11/2020   doi:10.1002/cac2.12088
Analysis of genetic alterations identifies the frequent mutation of GNAS in colorectal laterally spreading tumors
Yanying Nong, Yuru Zhang, Yi Zhang, Lei Pan, Junsheng Chen, Chaojun Zhu, Lu Han, Aimin Li, Side Liu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/6/2020   doi:10.1002/cac2.12085
Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?
Giovanni Brandi, Angela Dalia Ricci, Alessandro Rizzo, Chiara Zanfi, Simona Tavolari, Andrea Palloni, Stefania De Lorenzo, Matteo Ravaioli, Matteo Cescon
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/6/2020   doi:10.1002/cac2.12072
Emerging radiotherapy technologies and trends in nasopharyngeal cancer
Michelle Tseng, Francis Ho, Yiat Horng Leong, Lea Choung Wong, Ivan Wk Tham, Timothy Cheo, Anne Wm Lee
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/3/2020   doi:10.1002/cac2.12082

more papers...






Gastric cancer  

 

Edited by Yun Dai and Li Yan
 

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  

 

Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


 

Edited by Lin Yan and Wei Zhang  

 

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

 

Read thematic series > 



CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East,Guangzhou 510060, P.R.China